Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

488
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
488
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

439
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
439
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

762
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
762
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

822
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
822
Vaccinations01:51

Vaccinations

50.9K
Overview
50.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IFNγ blockade in Mycobacterium tuberculosis infected macaques alters the granuloma environment but not bacterial control.

Nature communications·2026
Same author

Glucocorticoids suppress early lung inflammation and impair control of SARS-CoV-2 in non-human primates.

PloS one·2026
Same author

Protein kinase F regulates the virulence of <i>Mycobacterium tuberculosis</i>.

bioRxiv : the preprint server for biology·2026
Same author

A gut commensal protozoan determines respiratory disease outcomes by shaping pulmonary immunity.

Cell·2024
Same author

The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication.

Science immunology·2024
Same author

Exhausted CD8 T cells and anti-inflammatory macrophages characterize lepromatous leprosy lesions.

EBioMedicine·2024

Related Experiment Video

Updated: Dec 28, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.8K

Routemaps for Highly Effective Tuberculosis Vaccination.

Maike Assmann1, Katrin D Mayer-Barber1

  • 1Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Immunity
|February 21, 2020
PubMed
Summary
This summary is machine-generated.

Developing a highly effective tuberculosis vaccine remains a challenge. New research shows that altering vaccine delivery routes and using protein subunit vaccines with adjuvants can significantly improve protection against tuberculosis infection and disease.

More Related Videos

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.9K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.4K

Related Experiment Videos

Last Updated: Dec 28, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.8K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.9K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.4K

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Tuberculosis (TB) remains a significant global health threat, with no highly effective vaccine currently available.
  • Existing TB vaccines offer limited protection, necessitating the development of novel strategies.

Purpose of the Study:

  • To explore new approaches for enhancing tuberculosis vaccine efficacy.
  • To establish new benchmarks for protection against TB infection and pulmonary disease.

Main Methods:

  • Investigating alternative routes for vaccine delivery.
  • Utilizing a protein subunit vaccine formulation.
  • Incorporating a potent adjuvant to enhance immune response.

Main Results:

  • Demonstrated improved protection against tuberculosis infection.
  • Showcased enhanced efficacy in preventing pulmonary disease.
  • Established new benchmarks in TB vaccine development.

Conclusions:

  • Modifying vaccine delivery routes and using protein subunit vaccines with adjuvants represent promising strategies for developing more effective tuberculosis vaccines.